✦ LIBER ✦

Cytomegalovirus Infection Prophylaxis Using Lower Dose Valganciclovir in Cardiac Transplant Patients: A Retrospective Analysis of Efficacy and Safety

✍ Scribed by Grayburn, Ryan; Anigbogu, Michael; Godden, Jon; Cho, Chi; Zwicke, Dianne; Cheema, Omar; Hastings, T. Edward; Sulemanjee, Nasir

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Valganciclovir prophylaxis for cytomegal

✍ S. Lefeuvre; P. Chevalier; C. Charpentier; R. Zekkour; L. Havard; M. Benammar; C 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB

Efficacy and Safety of Low-Dose Valganci

✍ Dr. Steven Gabardi; Dr. Colm C. Magee; Dr. Steven A. Baroletti; Dr. John A. Powe 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

The Efficacy and Safety of 200 Days Valg

✍ A. Humar; Y. Lebranchu; F. Vincenti; E. A. Blumberg; J. D. Punch; A. P. Limaye; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 382 KB

Impact of Cytomegalovirus Disease in D+/

✍ F. L. Luan; M. Kommareddi; A. O. Ojo 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB

Regarding: Humar et al. The Efficacy and

✍ C. da Cunha-Bang; M. Iversen; S. A. Mortensen; A. Rasmussen; H. Sengeløv; S. S. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 34 KB

Recombinant Factor VIIa Treatment of Sev

✍ Faisal Masud; Fariedeh Bostan; Elisa Chi; Steven E. Pass; Hany Samir; Karla Stue 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 260 KB